Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1993 Nov;46(11):1036–1038. doi: 10.1136/jcp.46.11.1036

Iron overload in multiply transfused patients who are HIV seropositive.

R D Goldin 1, M Wilkins 1, S Dourakis 1, J Parkin 1, R Lindley 1
PMCID: PMC501690  PMID: 8254092

Abstract

AIMS--To assess histologically the amount of iron deposited in liver biopsy specimens from HIV positive patients; and to perform estimations of liver iron on tissue from patients with an increase in parenchymal stainable iron. To correlate the amount of blood transfused and the degree of iron overload. METHODS--Liver biopsy specimens (n = 120) from 109 HIV positive patients, 74 of whom had AIDS, were examined retrospectively and the amount of iron, as visualised with Perls's stain, was graded. Fibrosis was assessed using connective tissue stains. Estimations of liver iron were performed on tissue retrieved from paraffin wax blocks in cases with histological grade 3 or 4 iron overload. The amount of blood transfused before liver biopsy was determined from the notes for each patient. RESULTS--Fifteen of the 120 liver biopsy specimens had significantly increased amounts of iron in their hepatocytes, as assessed histologically, and this was confirmed in seven cases by measurement of liver iron. There was a close correlation between the amount of blood transfused and the degree of iron overload. In the initial biopsy specimens only one case showed portal tract expansion. Three of the five patients who had repeat biopsies, however, showed progressive fibrosis. CONCLUSION--Multiply transfused HIV positive patients may develop clinically important iron overload and are at risk of developing progressive fibrosis. Superimposed liver disease, especially viral hepatitis, in these high risk patients may exacerbate the effects of the iron overload.

Full text

PDF
1036

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry M. Liver iron concentration, stainable iron, and total body storage iron. Gut. 1974 May;15(5):411–415. doi: 10.1136/gut.15.5.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Goldin R. D., Fish D. E., Hay A., Waters J. A., McGarvey M. J., Main J., Thomas H. C. Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection. J Clin Pathol. 1990 Mar;43(3):203–205. doi: 10.1136/jcp.43.3.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gordon S. C., Reddy K. R., Gould E. E., McFadden R., O'Brien C., De Medina M., Jeffers L. J., Schiff E. R. The spectrum of liver disease in the acquired immunodeficiency syndrome. J Hepatol. 1986;2(3):475–484. doi: 10.1016/s0168-8278(86)80059-9. [DOI] [PubMed] [Google Scholar]
  4. Lindley R., Parkin J., Durakis S., Goldin R. Iron deposition in liver in zidovudine-related transfusion-dependent anaemia. Lancet. 1989 Sep 16;2(8664):681–681. doi: 10.1016/s0140-6736(89)90929-x. [DOI] [PubMed] [Google Scholar]
  5. Milder M. S., Cook J. D., Stray S., Finch C. A. Idiopathic hemochromatosis, an interim report. Medicine (Baltimore) 1980 Jan;59(1):34–49. doi: 10.1097/00005792-198001000-00002. [DOI] [PubMed] [Google Scholar]
  6. Nakanuma Y., Liew C. T., Peters R. L., Govindarajan S. Pathologic features of the liver in acquired immune deficiency syndrome (AIDS). Liver. 1986 Jun;6(3):158–166. doi: 10.1111/j.1600-0676.1986.tb00283.x. [DOI] [PubMed] [Google Scholar]
  7. Richman D. D., Fischl M. A., Grieco M. H., Gottlieb M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Hirsch M. S. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):192–197. doi: 10.1056/NEJM198707233170402. [DOI] [PubMed] [Google Scholar]
  8. Risdon R. A., Barry M., Flynn D. M. Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia. J Pathol. 1975 Jun;116(2):83–95. doi: 10.1002/path.1711160204. [DOI] [PubMed] [Google Scholar]
  9. Rowe J. W., Wands J. R., Mezey E., Waterbury L. A., Wright J. R., Tobin J., Andres R. Familial hemochromatosis: characteristics of the precirrhotic stage in a large kindred. Medicine (Baltimore) 1977 May;56(3):197–211. [PubMed] [Google Scholar]
  10. SCHEUER P. J., WILLIAMS R., MUIR A. R. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol. 1962 Jul;84:53–64. [PubMed] [Google Scholar]
  11. Walker R. E., Parker R. I., Kovacs J. A., Masur H., Lane H. C., Carleton S., Kirk L. E., Gralnick H. R., Fauci A. S. Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. Ann Intern Med. 1988 Mar;108(3):372–376. doi: 10.7326/0003-4819-108-3-372. [DOI] [PubMed] [Google Scholar]
  12. Wilkins M. J., Lindley R., Dourakis S. P., Goldin R. D. Surgical pathology of the liver in HIV infection. Histopathology. 1991 May;18(5):459–464. doi: 10.1111/j.1365-2559.1991.tb00878.x. [DOI] [PubMed] [Google Scholar]
  13. Yarchoan R., Klecker R. W., Weinhold K. J., Markham P. D., Lyerly H. K., Durack D. T., Gelmann E., Lehrman S. N., Blum R. M., Barry D. W. Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet. 1986 Mar 15;1(8481):575–580. doi: 10.1016/s0140-6736(86)92808-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES